Please consider downloading the latest version of Internet Explorer
to experience this site as intended.
Tools Search Main Menu

Tag: cancer

Another piece to the puzzle in naked mole rats’ long, cancer-free life

Another piece to the puzzle in naked mole rats’ long, cancer-free life

February 6, 2018

Rochester biologists were surprised to see that despite its remarkable longevity, the naked mole rat still has cells that undergo senescence, like the cells in much shorter-lived mice.

Continue Reading

Research is changing the game for melanoma treatment

Research is changing the game for melanoma treatment

February 1, 2018

Some Wilmot Cancer Institute patients with advanced melanoma may have longer disease-free survival thanks to new drug treatment options tested by Rochester researchers.

Continue Reading

Pancreatic tumors may require a one-two-three punch

Pancreatic tumors may require a one-two-three punch

January 15, 2018

Wilmot Cancer Institute scientists have discovered that a three-drug combination can simultaneously target the cancer cells as well as the other harmful, inflammatory cells within the tumor.

Continue Reading

Newest data links inflammation to chemo-brain

Newest data links inflammation to chemo-brain

December 14, 2017

Chemo-brain, or cancer-related cognitive impairment, is estimated to impact 80 percent of people in treatment. A new Medical Center study shows that inflammation in the blood plays a key role.

Continue Reading

Rochester chemists find new means to ‘block’ cancer cell growth

Rochester chemists find new means to ‘block’ cancer cell growth

October 31, 2017

A pathway that enables embryonic cells to develop into different organs can be reactivated by cancer cells. A cyclic peptide has been found that can block the activation of this pathway, and is also less likely to trigger resistance in cancer cells.

Continue Reading

‘Microbubbles’ boost search for head, neck cancer treatment

‘Microbubbles’ boost search for head, neck cancer treatment

October 25, 2017

A Medical Center team recently received a $3.8 million grant to continue their investigation of an innovative technology that could lead to preventative treatments for radiation damage in patients.

Continue Reading

Rochester positioned among first to offer FDA approved cancer therapy

Rochester positioned among first to offer FDA approved cancer therapy

October 20, 2017

UR Medicine’s Wilmot Cancer Institute will be among the first sites in the world to offer CAR T-cell therapy —a new type of immunotherapy approved this week by the FDA—to adults with aggressive lymphoma. The engineered gene therapy has been described as a revolutionary “living drug” and one of the most powerful cancer treatments to emerge in recent years.

Continue Reading

Protein identified in post-chemo cell death puzzle

Protein identified in post-chemo cell death puzzle

September 11, 2017

Researchers have identified a protein that is required for cell death after undergoing chemotherapy—at least, it appears, in male mice.

Continue Reading

Cancer patients fare much worse after cardiac arrest

Cancer patients fare much worse after cardiac arrest

August 2, 2017

Patients with advanced cancer who suffer cardiac arrest in a hospital have a survival rate of less than 10 percent—half the rate of patients without cancer, according to a nationwide study led by the Medical Center.

Continue Reading

Can the sunshine vitamin help lymphoma patients?

Can the sunshine vitamin help lymphoma patients?

July 19, 2017

A new $3 million grant to the Wilmot Cancer Institute allows oncologists to evaluate whether adding vitamin D to standard therapy will help cancer patients live longer.

Continue Reading